Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B

Journal of Biological Chemistry

Volumn 266, Issue 32, 1991, Pages 21386-21391

  Wicker, G ^a   Prill, V ^a   Brooks, D ^a   Gibson, G ^a   Hopwood, J ^a   Von Figura, K ^a   Peters, C ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; N ACETYLGALACTOSAMINE 4 SULFATASE;

ARTICLE; HUMAN; HUMAN CELL; MAROTEAUX LAMY SYNDROME; MUTATION; PHENOTYPE; PRIORITY JOURNAL;

ALLELES; AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; CHONDRO-4-SULFATASE; CLONING, MOLECULAR; GLYCINE; HUMAN; KINETICS; MOLECULAR SEQUENCE DATA; MUCOPOLYSACCHARIDOSIS VI; MUTAGENESIS, SITE-DIRECTED; MUTATION; OLIGODEOXYRIBONUCLEOTIDES; PHENOTYPE; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RESTRICTION MAPPING; RNA; SUPPORT, NON-U.S. GOV'T; VALINE;

EID: 0025720685     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)